Quantcast
Press "Enter" to skip to content

The drug was available with good intentions, and then, came the terrifying greed

Drugs and healthcare are two topics that we take on often and we tend to ask the questions that piss off insurance and drug companies the most. The case for one drug that treats onset early paralysis, or temporary spells of it, that eventually go away.  Enter: Darandine

The Washington Post began the witchhunt into the medicine, which, has turned up some interesting information about its modern existence.    Per the Post,  Darandine was first discovered in the 50’s and used for a multitude of purposes including treating all kinds of temporary paralysis. The medicine, ehum, had primarily for nearly half a century been used to combat the troubling symptoms of the rare genetic disorder.

So, what’s the flub over the price? In 2001, per the Post,    the pills would have cost around $50 for 100 pills. Now? Fast forward from the 50’s to about 2015, and, Per The Post,  the last available records put the price at about $13,500 for 100 pills.

Yes, that’s more than a 300% increase.   The last records apparently available, show, that the drug was last owned by Sun Pharma who quietly jacked the price up in 2015 despite calls for it to remain cheap.  The Post apparently intends to continue their investigation.

Be First to Comment

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Verified by MonsterInsights